Citurgia Biochemicals Ltd Financials
Company Logo

Citurgia Biochemicals Ltd Financial Statement

Citurgia Biochemicals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
RevenueTBA
Operating Expense0.08
Net Profit-0.14
Net Profit MarginTBA
Earning Per Share-0.01
EBIDTA-0.08
Effective Tax RateTBA
Invest in Citurgia Biochemicals Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Citurgia Biochemicals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue AnnualTBA
Operating Expenses Annual0.25
Operating Profit Annual-0.25
Interest Annual0.00
Depreciation0.23
Net Profit Annual-0.48
Tax AnnualTBA

Citurgia Biochemicals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.08
Cash Flow from Operations-0.14
Cash Flow from Investing-0.05
Cash Flow from Financing0.22
Cash Flow at the End0.10

Citurgia Biochemicals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)TBA
PBIT Margin (%)TBA
PBT Margin (%)TBA
Net PROFIT Margin (%)TBA
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)TBA
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)TBA

Citurgia Biochemicals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.85
Total Current Assets Annual8.30
Non Current Assets Annual2.74
Total Shareholders Funds Annual-6.57
Total Assets Annual11.04

Citurgia Biochemicals Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 23, 2024, Citurgia Biochemicals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
Yes, Citurgia Biochemicals Ltd is debt-free with a debt-to-equity ratio of -1.03.
In FY 2023 , Citurgia Biochemicals Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.
Citurgia Biochemicals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and NaN% annually, respectively..
Citurgia Biochemicals Ltd's current PE ratio is undefined.
Citurgia Biochemicals Ltd's ROCE averaged -89.1% from the FY ending March 2022 to 2024, with a median of -75.7%. It peaked at -42.3% in March 2022, reflecting strong capital efficiency over the period..
Citurgia Biochemicals Ltd's latest EBIT is Rs. -0.48 Cr, surpassing the average EBIT of Rs. -0.44 Cr over the 5 years..